Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 2
1995 1
1996 1
1998 2
1999 1
2001 3
2002 1
2003 2
2004 1
2005 2
2012 1
2013 6
2014 2
2015 1
2016 2
2017 1
2018 1
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Screening for diabetic retinopathy: new perspectives and challenges.
Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, Peto T, Simó R. Vujosevic S, et al. Among authors: aldington sj. Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347. doi: 10.1016/S2213-8587(19)30411-5. Epub 2020 Feb 27. Lancet Diabetes Endocrinol. 2020. PMID: 32113513 Free article. Review.
Epidemiological issues in diabetic retinopathy.
Scanlon PH, Aldington SJ, Stratton IM. Scanlon PH, et al. Among authors: aldington sj. Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):293-300. doi: 10.4103/0974-9233.120007. Middle East Afr J Ophthalmol. 2013. PMID: 24339678 Free PMC article. Review.
Risk stratification for diabetic eye screening.
Stratton IM, Aldington SJ. Stratton IM, et al. Among authors: aldington sj. Diabetologia. 2014 Jan;57(1):259. doi: 10.1007/s00125-013-3060-4. Epub 2013 Sep 22. Diabetologia. 2014. PMID: 24057137 No abstract available.
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
Simó R, Hernández C, Porta M, Bandello F, Grauslund J, Harding SP, Aldington SJ, Egan C, Frydkjaer-Olsen U, García-Arumí J, Gibson J, Lang GE, Lattanzio R, Massin P, Midena E, Ponsati B, Ribeiro L, Scanlon P, Lobo C, Costa MÂ, Cunha-Vaz J; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Simó R, et al. Among authors: aldington sj. Diabetes. 2019 Feb;68(2):457-463. doi: 10.2337/db18-0682. Epub 2018 Nov 2. Diabetes. 2019. PMID: 30389750 Clinical Trial.
Quality assurance for diabetic retinopathy telescreening.
Schneider S, Aldington SJ, Kohner EM, Luzio S, Owens DR, Schmidt V, Schuell H, Zahlmann G. Schneider S, et al. Among authors: aldington sj. Diabet Med. 2005 Jun;22(6):794-802. doi: 10.1111/j.1464-5491.2005.01512.x. Diabet Med. 2005. PMID: 15910634
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
Hernández C, Porta M, Bandello F, Grauslund J, Harding SP, Aldington SJ, Egan C, Frydkjaer-Olsen U, García-Arumí J, Gibson J, Lang GE, Lattanzio R, Massin P, Midena E, Ponsati B, Ribeiro L, Scanlon P, Cunha-Vaz J, Simó R. Hernández C, et al. Among authors: aldington sj. J Clin Med. 2020 Apr 24;9(4):1233. doi: 10.3390/jcm9041233. J Clin Med. 2020. PMID: 32344735 Free PMC article.
31 results